Elena Villamanan

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study.

Early Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort Study.

Journal: Archivos de bronconeumologia

Published: April 27, 2026

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Tezepelumab in Allergic Bronchopulmonary Aspergillosis With Severe Uncontrolled Asthma: A Retrospective 4-Case Series.

Journal: Journal of investigational allergology & clinical immunology

Published: April 22, 2026

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use.

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β2-Agonist and Short-Acting Muscarinic Antagonist Use.

Journal: Biomedicines

Published: April 22, 2026

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Journal: Archivos de bronconeumologia

Published: December 30, 2025

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.

Journal: Respiration; international review of thoracic diseases

Published: October 01, 2025

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for tailored management.

Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for tailored management.

Journal: Respiration; international review of thoracic diseases

Published: October 01, 2025

Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.

Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.

Journal: PharmacoEconomics - open

Published: September 02, 2025

Eosinophil and Cationic Protein Levels in Patients Treated With Dupilumab: A Real-Life Study.

Eosinophil and Cationic Protein Levels in Patients Treated With Dupilumab: A Real-Life Study.

Journal: Open respiratory archives

Published: June 18, 2025

Inhalers and climate change: A sustainable approach to severe asthma management.

Inhalers and climate change: A sustainable approach to severe asthma management.

Journal: Respiratory medicine

Published: June 05, 2025

Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved.

Adherence to Intranasal Corticosteroids in Patients with Severe Asthma and Nasal Polyposis: Pharmacological and Clinical Factors Involved.

Journal: Journal of clinical medicine

Published: May 29, 2025

Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.

Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.

Journal: Archivos de bronconeumologia

Published: March 12, 2025

Efficacy Assessment of Biological Treatments in Severe Asthma.

Efficacy Assessment of Biological Treatments in Severe Asthma.

Journal: Journal of clinical medicine

Published: October 29, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026